• De streefwaarden van het HbA1c zijn aangepast. De intensiteit van de
diabetesbehandeling, leeftijd van de patiënt en de diabetesduur zijn factoren die van …

Exenatide, the gliptins and detemir were all clinically effective. The long-acting insulin
analogues glargine and detemir appeared to have only slight clinical advantages over NPH …

Aim: To evaluate the efficacy and safety of adding sitagliptin or glimepiride to the treatment
regimen of patients with type 2 diabetes mellitus and inadequate glycaemic control on …

Type 2 diabetes mellitus (T2DM) is a worldwide public health challenge. Despite the
availability of many antidiabetes agents and pharmacotherapies targeting cardiovascular …

Aim: Recent studies indicate that type 2 diabetes is associated with an increased secretion
of both hepatic and intestinal lipoproteins, leading to the accumulation of atherogenic …

Known treatments of type 2 diabetes mellitus have limitations such as weight gain, and
hypoglycaemias. A new perspective is the use of incretin hormones and incretin enhancers …

OBJECTIVE Patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease have
an increased risk of micro-and macrovascular disease, but limited options for …

Background Dipeptidyl peptidase‐4 inhibitors improve glycaemic control in patients with
type 2 diabetes mellitus when used as monotherapy or in combination with other anti …

В руководстве обобщены наиболее современные представления об этиологии,
патогенезе, диагностике, профилактике и лечении, а также возможностях медико …

BACKGROUND AND AIM: The role of Dipeptidyl Peptidase-4 (DPP-4) inhibitors in the
treatment of type 2 diabetes is debated; many recent trials, which were not included in …